Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats

Authors
Lee, Sang KyuKim, YoonKim, Tae KonIm, Guang-JinLee, Bong-YongKim, Dong-HyunJin, ChangbaeYoo, Hye Hyun
Issue Date
2009-02-20
Publisher
ELSEVIER SCIENCE BV
Citation
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.49, no.2, pp.513 - 518
Abstract
The purpose of the present study was to determine sildenafil and a novel PDE-5 inhibitor, mirodenafil in the plasma and corpus cavernosum tissue of rats to compare their pharmacokinetic Properties. The concentrations of mirodenafil and sildenafil in the rat plasma and corpus cavernosum tissue samples were analyzed using LC-MS/MS after a single oral administration at a dose of 40 mg/kg to rats. Although the T-max, D lambda(1/2) and MRT were not different between mirodenafil and sildenafil, the C-max and AUC of mirodenafil were significantly higher than those of sildenafil in the plasma and corpus cavernosum tissue. Consequently mirodenafil remained longer than sildenafil in the plasma and tissue. This may provide pharmacokinetic evidence for assessment of the in vivo efficacy of mirodenafil and sildenafil. (C) 2008 Elsevier B.V. All rights reserved.
Keywords
PHARMACOKINETICS; IDENTIFICATION; METABOLISM; PHARMACOKINETICS; IDENTIFICATION; METABOLISM; Mirodenafil; Sildenafil; Tissue distribution; LC-MS/MS
ISSN
0731-7085
URI
https://pubs.kist.re.kr/handle/201004/132731
DOI
10.1016/j.jpba.2008.11.004
Appears in Collections:
KIST Article > 2009
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE